HEADER HORMONE 15-MAY-15 2N2W TITLE SOLUTION STRUCTURE OF [B26-B29 TRIAZOLE CROSS-LINKED]-INSULIN ANALOGUE TITLE 2 AT PH 8.0 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN A CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INSULIN B CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606 KEYWDS HORMONE EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR V.VEVERKA,R.HEXNEROVA,J.JIRACEK REVDAT 1 03-FEB-16 2N2W 0 JRNL AUTH J.VIKOVA,M.COLLINSOVA,E.KLETVIKOVA,M.BUDESINSKY,V.KAPLAN, JRNL AUTH 2 L.ZAKOVA,V.VEVERKA,R.HEXNEROVA,R.J.AVINO,J.STRAKOVA, JRNL AUTH 3 I.SELICHAROVA,V.VANEK,D.W.WRIGHT,C.J.WATSON,J.P.TURKENBURG, JRNL AUTH 4 A.M.BRZOZOWSKI,J.JIRACEK JRNL TITL RATIONAL STEERING OF INSULIN BINDING SPECIFICITY BY JRNL TITL 2 INTRA-CHAIN CHEMICAL CROSSLINKING. JRNL REF SCI REP V. 6 19431 2016 JRNL REFN ESSN 2045-2322 JRNL PMID 26792393 JRNL DOI 10.1038/SREP19431 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : YASARA REMARK 3 AUTHORS : KRIEGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2N2W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAY-15. REMARK 100 THE RCSB ID CODE IS RCSB104353. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 8.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.5 MM CHAIN_A, 1.5 MM CHAIN_B, REMARK 210 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 23 TYR B 16 CE1 TYR B 16 CZ 0.082 REMARK 500 28 TYR A 19 CD1 TYR A 19 CE1 0.099 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 8 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 18 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 19 ARG B 22 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 21 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 8 35.46 -80.55 REMARK 500 1 VAL B 2 -164.00 -101.20 REMARK 500 1 ASN B 3 -150.51 -122.42 REMARK 500 1 GLN B 4 169.13 68.05 REMARK 500 2 THR A 8 28.96 -77.70 REMARK 500 2 CYS A 11 112.98 67.95 REMARK 500 3 THR A 8 21.76 -77.67 REMARK 500 3 ASN B 3 -153.26 -84.36 REMARK 500 3 GLN B 4 166.91 78.51 REMARK 500 3 GLU B 21 -24.23 66.69 REMARK 500 4 SER A 12 131.12 65.41 REMARK 500 4 ASN B 3 -113.45 66.23 REMARK 500 4 GLN B 4 176.22 64.76 REMARK 500 4 ARG B 22 -98.92 -164.97 REMARK 500 5 ASN B 3 -108.00 62.47 REMARK 500 5 GLN B 4 173.54 63.99 REMARK 500 5 CYS B 7 -48.93 -154.02 REMARK 500 5 GLU B 21 -35.12 66.21 REMARK 500 5 ARG B 22 66.15 -69.60 REMARK 500 5 THR B 27 155.32 73.08 REMARK 500 6 ILE A 2 -36.07 -135.74 REMARK 500 6 SER A 12 120.51 64.52 REMARK 500 6 ASN B 3 72.43 53.10 REMARK 500 6 CYS B 7 -61.85 -156.36 REMARK 500 6 ARG B 22 -175.29 78.15 REMARK 500 6 PHE B 25 96.66 47.64 REMARK 500 7 CYS A 7 -77.51 -71.36 REMARK 500 7 SER A 12 129.02 71.71 REMARK 500 7 VAL B 2 119.39 74.69 REMARK 500 7 GLN B 4 40.88 -157.93 REMARK 500 7 HIS B 5 92.78 52.44 REMARK 500 7 GLU B 21 -45.64 -148.03 REMARK 500 7 PHE B 24 -42.45 -167.04 REMARK 500 7 NVA B 26 5.36 -69.48 REMARK 500 7 THR B 27 165.91 74.44 REMARK 500 8 ILE A 2 -26.73 -149.25 REMARK 500 8 THR A 8 29.00 -78.61 REMARK 500 8 GLU B 21 -49.20 71.04 REMARK 500 9 ILE A 2 -32.45 -137.32 REMARK 500 9 ASN B 3 -127.06 56.38 REMARK 500 9 GLN B 4 166.27 78.89 REMARK 500 9 GLU B 21 -43.74 -132.55 REMARK 500 9 PHE B 24 -38.47 -136.88 REMARK 500 9 PHE B 25 94.93 57.90 REMARK 500 10 THR A 8 35.49 -80.23 REMARK 500 10 CYS A 11 -170.28 66.17 REMARK 500 10 VAL B 2 94.96 70.88 REMARK 500 10 THR B 27 158.67 70.85 REMARK 500 11 VAL B 2 -100.15 66.09 REMARK 500 11 GLU B 21 -33.12 -158.49 REMARK 500 REMARK 500 THIS ENTRY HAS 139 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25614 RELATED DB: BMRB REMARK 900 RELATED ID: 2N2V RELATED DB: PDB REMARK 900 RELATED ID: 2N2X RELATED DB: PDB DBREF 2N2W A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2N2W B 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 2N2W NVA B 26 UNP P01308 TYR 50 ENGINEERED MUTATION SEQADV 2N2W HIX B 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE NVA SEQRES 3 B 30 THR PRO HIX THR MODRES 2N2W NVA B 26 VAL NORVALINE MODRES 2N2W HIX B 29 ALA 3-(1H-1,2,3-TRIAZOL-5-YL)-L-ALANINE HET NVA B 26 15 HET HIX B 29 17 HETNAM NVA NORVALINE HETNAM HIX 3-(1H-1,2,3-TRIAZOL-5-YL)-L-ALANINE FORMUL 2 NVA C5 H11 N O2 FORMUL 2 HIX C5 H8 N4 O2 HELIX 1 1 GLY A 1 THR A 8 1 8 HELIX 2 2 SER A 12 ASN A 18 1 7 HELIX 3 3 GLY B 8 CYS B 19 1 12 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.03 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.03 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.02 LINK C HIX B 29 N THR B 30 1555 1555 1.35 LINK C PHE B 25 N NVA B 26 1555 1555 1.34 LINK C NVA B 26 N THR B 27 1555 1555 1.35 LINK C PRO B 28 N HIX B 29 1555 1555 1.35 LINK CD NVA B 26 NE2 HIX B 29 1555 1555 1.48 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1